Fig. 3From: The mode of progressive disease affects the prognosis of patients with metastatic breast cancerThe distribution of the chemotherapy drugs used in first-, second-, and third-line chemotherapy and the frequency of new lesions (NL) in each drug. The distribution of the chemotherapy drugs at (a) first-line chemotherapy, (b) second-line chemotherapy, and (c) third-line chemotherapy, and the frequency of NL at (d) first-line chemotherapy, (e) second-line chemotherapy, and (f) third-line chemotherapy. PTX + BV, paclitaxel with bevacizumabBack to article page